Metastatic Cutaneous Melanoma Clinical Trials

17 clinical trials for Metastatic Cutaneous Melanoma across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer — RECRUITING · PHASE1
• Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program — RECRUITING · PHASE2
• Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma — RECRUITING · PHASE1
• Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial — RECRUITING · PHASE2
• A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases — RECRUITING · PHASE2
• Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade — RECRUITING · PHASE2
• Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery — ACTIVE_NOT_RECRUITING · PHASE3
• Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) — TERMINATED · PHASE2
• Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy — NOT_YET_RECRUITING · PHASE1
• Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer — SUSPENDED · NA
• Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial — NOT_YET_RECRUITING · PHASE2
• Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases — COMPLETED · PHASE1
• Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma — NOT_YET_RECRUITING · PHASE1
• Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma — TERMINATED · PHASE2
• Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases — NOT_YET_RECRUITING · PHASE1
• A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma — WITHDRAWN · PHASE1
• Drosophila-generated CTL — TERMINATED · PHASE2

Refine this search